Delivery Order SPE2DB20D2014-SPE2DB24FC92C

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $2,377.32 and a period of performance through May 14, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $13,618.40 and a period of performance through August 30, 2024. This order is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies to provide a wide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg VEKLURY (remdesivir) vials. The contract has a ceiling value of $13,618.40 and an ultimate completion date of September 20, 2024. It is a firm-fixed-price contract and does not utilize any set-aside designations. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,754.64, is for the delivery of the drug VEKLURY (Remdesivir) 100 mg vials. It is a firm fixed-price contract with a completion date of June 2, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,213.60 firm fixed-price delivery order is for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a completion date of July 26, 2022 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This contract award to AmerisourceBergen Drug Corp is a delivery order worth $6,809.20 for the supply of Veklury (remdesivir) 100 mg vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract has an ultimate completion date of October 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VEKLURY (Remdesivir) 100 mg vials. The delivery order, valued at $3,404.60, is a firm fixed-price contract with a period of performance through August 16, 2024. The award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Veklury (remdesivir) 100 mg vials. The $13,618.40 firm fixed price contract has a period of performance through August 9, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC92C
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $8,511.50 and an ultimate completion date of September 24, 2024. The award is a firm fixed-price contract with no set-aside designation.

AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential medical supplies, including prescription medications, vaccines, and medical equipment. These contracts support the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations and healthcare settings.

Generated 12/3/24, 10:05 AM